RY 175.58 0.8443% SHOP 151.59 -0.941% TD 82.1 0.2932% ENB 64.44 0.0621% BN 85.46 0.8259% TRI 236.35 0.0381% CNQ 45.69 0.6609% CP 114.79 1.7281% CNR 153.65 2.3106% BMO 144.17 0.0972% BNS 74.34 0.3916% CSU 4540.9302 0.9091% CM 91.75 0.2294% MFC 44.24 1.0276% ATD 76.64 0.4193% NGT 59.7 -0.3672% TRP 67.94 0.0736% SU 56.64 0.3544% WCN 257.31 0.1674% L 186.83 1.5656%

Hemostemix Inc

Healthcare CA HEM

0.315CAD
0.04(12.50%)

Last update at 2025-01-23T17:46:00Z

Day Range

0.280.32
LowHigh

52 Week Range

0.040.11
LowHigh

Fundamentals

  • Previous Close 0.28
  • Market Cap14.21M
  • Volume741166
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.53341M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.02

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.74855M -6.54150M -7.76850M -4.86980M -6.18146M
Minority interest - - - - -
Net income -5.23547M -6.28572M -7.76850M -4.86980M -6.18769M
Selling general administrative 3.95M 6.47M 6.81M 2.34M 4.16M
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation 0.00049M 0.00110M 0.00245M 0.00169M -
Ebit -4.57801M - -4.87890M -4.64334M -6.42310M
Ebitda -4.39774M -6.52992M -7.66000M -4.76313M -6.42310M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -4.57801M -6.65582M -7.46635M -4.69618M -6.42310M
Other operating expenses - - - - -
Interest expense 0.35M 0.01M 0.11M 0.10M 0.00000M
Tax provision 0.49M -0.25578M - - 0.00000M
Interest income - 0.07M - 0.00000M -
Net interest income -0.35402M -0.02085M -0.11303M -0.10498M 0.02M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.49M - - - -
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 4.58M 6.66M 7.47M 4.70M 6.42M
Cost of revenue - - - - -
Total other income expense net 0.18M 0.14M -0.18911M -0.06864M 0.22M
Discontinued operations - - - - -0.00622M
Net income from continuing ops -5.23547M -6.28572M -7.76850M -4.86980M -6.18146M
Net income applicable to common shares -5.23547M -5.23547M -7.76850M -4.86980M -6.18769M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 0.31M 0.47M 0.56M 2.32M 0.10M
Intangible assets 0.00000M - - 0.00000M 0.00000M
Earning assets - - - - -
Other current assets 0.13M - - - -
Total liab 7.68M 7.23M 5.85M 3.42M 4.15M
Total stockholder equity -7.37123M -6.76873M -5.28379M -1.09870M -4.04514M
Deferred long term liab